跳至主要内容
临床试验/CTRI/2024/05/068110
CTRI/2024/05/068110已完成2 期

Utility of remedies from Ranunculaceae family in cases of Migraine

Dr jigar Parikh1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年6月13日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Eleven – point pain scale

研究概览

简要总结

This study is Prospective pretest posttest interventional trial UTILITY OF REMEDIES FROM RANUNCULACEAE FAMILY IN CASES OF MIGRAINE as per inclusion and exclusion criteria from outpatient department 40 participants will be selected by non-probability sampling outcome will be measured by assessment of Eleven – point pain scale and MIDAS score at baseline and at end of treatment

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
12.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Already diagnosed cases of migraine Age group: 12 – 65 years Sex: Male, Female and Transgender Pain severity more than 5 on eleven-point pain scale MIDAS disability score less than 20.

排除标准

  • Co morbid gross pathology of CNS Severe disability or equal to 20 on MIDAS Pregnancy and lactating female Patients who are not able to fill Eleven point pain scale and MIDAS Status migrainosus persistent aura without infarction migrainosus infarction and migraine aura triggered seizure.

结局指标

主要结局

Eleven – point pain scale

时间窗: data will be taken at baseline and at end of treatment of eight months of duration to assess changes

次要结局

  • MIDAS score(Data will be taken at baseline of treatment and  at end of treatment of eight months of)

研究者

发起方
Dr jigar Parikh
申办方类型
Other [self ]
责任方
Principal Investigator
主要研究者

Dr Jigar Parikh

SMT A J Savala Homoeopathic medcal college and research institute Mehsana Gujarat

研究点 (1)

Loading locations...

相似试验

Usefulness of medicines from Ranunculaceae family in... | 临床试验